Earnings estimate revisions

Search documents
CAE (CAE) Matches Q1 Earnings Estimates
ZACKSยท 2025-08-12 22:36
Group 1: Earnings Performance - CAE reported quarterly earnings of $0.15 per share, matching the Zacks Consensus Estimate, and consistent with earnings from the previous year [1] - The company posted revenues of $793.98 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 1.99%, but showing an increase from $783.87 million year-over-year [2] - Over the last four quarters, CAE has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2][3] Group 2: Stock Performance and Outlook - CAE shares have increased approximately 13.3% since the beginning of the year, outperforming the S&P 500's gain of 8.4% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.18 on revenues of $852.69 million, and for the current fiscal year, it is $0.97 on revenues of $3.56 billion [7] Group 3: Industry Context - The Aerospace - Defense Equipment industry, to which CAE belongs, is currently ranked in the bottom 38% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact CAE's stock performance [5][6]
Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates
ZACKSยท 2025-08-12 22:11
Group 1 - Lineage Cell (LCTX) reported a quarterly loss of $0.01 per share, better than the Zacks Consensus Estimate of a loss of $0.02, and improved from a loss of $0.03 per share a year ago, representing an earnings surprise of +50.00% [1] - The company posted revenues of $2.77 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 75.00%, compared to year-ago revenues of $1.41 million [2] - Lineage Cell shares have increased approximately 101% since the beginning of the year, significantly outperforming the S&P 500's gain of 8.4% [3] Group 2 - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The estimate revisions trend for Lineage Cell was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $2.52 million, and -$0.09 on revenues of $7.94 million for the current fiscal year [7] Group 3 - The Medical - Biomedical and Genetics industry, to which Lineage Cell belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, which may impact stock performance [8] - Another company in the same industry, Biofrontera Inc. (BFRI), is expected to report a quarterly loss of $0.45 per share, reflecting a year-over-year change of +59.8%, with revenues anticipated to be $8.2 million, up 4.6% from the previous year [9]
York Water (YORW) Beats Q2 Earnings and Revenue Estimates
ZACKSยท 2025-08-12 20:06
Core Viewpoint - York Water (YORW) reported quarterly earnings of $0.35 per share, exceeding the Zacks Consensus Estimate of $0.33 per share, with a year-over-year comparison showing no change in earnings [1][2] Financial Performance - The company achieved revenues of $19.2 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.05%, compared to $18.75 million in the same quarter last year [2] - Over the last four quarters, York Water has exceeded consensus EPS estimates only once [2] Stock Performance - York Water shares have declined approximately 5.5% since the beginning of the year, while the S&P 500 has gained 8.4% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.41 on revenues of $21 million, and for the current fiscal year, it is $1.33 on revenues of $78 million [7] - The trend of estimate revisions for York Water was mixed prior to the earnings release, which may change following the recent report [6] Industry Context - The Utility - Water Supply industry, to which York Water belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]
Earnings Estimates Rising for Xometry (XMTR): Will It Gain?
ZACKSยท 2025-08-12 17:21
Core Viewpoint - Xometry (XMTR) is experiencing solid improvement in earnings estimates, which is likely to positively impact its stock price in the near term [1][2]. Earnings Estimates - Analysts are increasingly optimistic about Xometry's earnings prospects, leading to higher estimates that should reflect in the stock price [2]. - The consensus earnings estimate for the current quarter is $0.11 per share, indicating a year-over-year increase of +450.0% [5]. - For the full year, the earnings estimate has risen to $0.35 per share, representing a change of +975.0% from the previous year [6]. Estimate Revisions - Over the past 30 days, the Zacks Consensus Estimate for Xometry has increased by 5%, with one estimate moving higher and no negative revisions [5]. - The consensus estimate for the current year has increased by 18.63%, with three estimates moving higher and no negative revisions [6][7]. Zacks Rank - Xometry has earned a Zacks Rank 2 (Buy) due to promising estimate revisions, which indicates a favorable investment opportunity [8]. - Stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) have historically outperformed the S&P 500 [8]. Stock Performance - Xometry's stock has increased by 29.5% over the past four weeks, driven by strong estimate revisions and investor interest [9].
ITT (ITT) Moves to Buy: Rationale Behind the Upgrade
ZACKSยท 2025-08-12 17:01
Investors might want to bet on ITT (ITT) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earnings picture is a ...
Xeris Biopharma (XERS) Upgraded to Buy: Here's Why
ZACKSยท 2025-08-12 17:01
Xeris Biopharma (XERS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The power ...
Synchronoss (SNCR) Q2 Earnings and Revenues Miss Estimates
ZACKSยท 2025-08-12 00:06
Core Insights - Synchronoss (SNCR) reported quarterly earnings of $0.1 per share, missing the Zacks Consensus Estimate of $0.25 per share, and down from $0.48 per share a year ago, indicating a -60.00% earnings surprise [1] - The company posted revenues of $42.49 million for the quarter ended June 2025, slightly missing the Zacks Consensus Estimate by 0.24%, and down from $43.46 million year-over-year [2] - Synchronoss shares have declined approximately 18.5% since the beginning of the year, contrasting with the S&P 500's gain of 8.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.31 on revenues of $42.96 million, and for the current fiscal year, it is $1.17 on revenues of $172.42 million [7] - The estimate revisions trend for Synchronoss was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Internet - Software industry, to which Synchronoss belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting that companies in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - Another company in the same industry, KORE Group Holdings, is expected to report a quarterly loss of $0.47 per share, reflecting a year-over-year change of +52.5%, with revenues anticipated at $70.3 million, up 3.6% from the previous year [9][10]
VirTra, Inc. (VTSI) Q2 Earnings Miss Estimates
ZACKSยท 2025-08-12 00:06
Company Performance - VirTra, Inc. (VTSI) reported quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.03 per share, and down from $0.11 per share a year ago, representing an earnings surprise of -33.33% [1] - The company posted revenues of $6.98 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 9.39%, compared to year-ago revenues of $6.07 million [2] - Over the last four quarters, VirTra has surpassed consensus EPS estimates just once, but has topped consensus revenue estimates three times [2] Future Outlook - The sustainability of VirTra's stock price movement will depend on management's commentary during the earnings call and future earnings expectations [3] - The current consensus EPS estimate for the coming quarter is $0.05 on revenues of $7.48 million, and for the current fiscal year, it is $0.27 on revenues of $29.19 million [7] - The estimate revisions trend for VirTra was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Electronics - Military industry, to which VirTra belongs, is currently in the top 41% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8]
Surging Earnings Estimates Signal Upside for DoorDash (DASH) Stock
ZACKSยท 2025-08-11 17:21
Group 1 - DoorDash, Inc. shows a noticeable improvement in earnings outlook, making it an attractive investment option [1] - Analysts are raising earnings estimates for DoorDash, indicating growing optimism about the company's earnings prospects [2][3] - The Zacks Rank system, which rates stocks from 1 (Strong Buy) to 5 (Strong Sell), has a strong track record, with 1 ranked stocks averaging a +25% annual return since 2008 [3] Group 2 - For the current quarter, DoorDash is expected to earn $0.67 per share, reflecting a +76.3% change from the previous year [6] - Over the past 30 days, eight estimates for DoorDash have increased, leading to a 6.15% rise in the Zacks Consensus Estimate [6] - For the full year, DoorDash's expected earnings are $2.38 per share, representing a significant year-over-year increase of +720.7% [7] Group 3 - DoorDash currently holds a Zacks Rank 1 (Strong Buy) due to favorable estimate revisions, which can help investors make informed decisions [8] - Stocks with Zacks Rank 1 and 2 tend to significantly outperform the S&P 500 [8] Group 4 - DoorDash's stock has increased by 7.8% over the past four weeks due to strong estimate revisions, suggesting potential for further upside [9]
Horace Mann (HMN) Upgraded to Buy: What Does It Mean for the Stock?
ZACKSยท 2025-08-11 17:01
Core Viewpoint - Horace Mann (HMN) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system reflects changes in earnings estimates, which are strongly correlated with stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - An increase in earnings estimates typically leads to higher fair value for a stock, prompting institutional investors to buy or sell, thus affecting stock prices [4]. Company Performance and Outlook - The upgrade for Horace Mann suggests an improvement in the company's underlying business, which should encourage investors to drive the stock price higher [5]. - Over the past three months, the Zacks Consensus Estimate for Horace Mann has increased by 6.3%, with expected earnings of $4.14 per share for the fiscal year ending December 2025, indicating no year-over-year change [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong track record of performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7]. - The upgrade to Zacks Rank 2 places Horace Mann in the top 20% of Zacks-covered stocks, suggesting it has superior earnings estimate revisions and potential for market-beating returns in the near term [10].